Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Peripheral Artery Disease

In brief

The goal of this mechanistic clinical trial is to test the effects of reducing inflammatory signaling in femoral artery atherosclerotic plaques. Researchers will compare patients receiving colchicine to patients receiving placebo to determine the effect of colchicine on the inflammatory state of atherosclerotic femoral arteries.

Key facts

Study ID
NCT06212271
Run by
University of Pennsylvania
People needed
24
Starts
2024-09-25
Expected to finish
2026-03-25
Last updated by the study team
2026-04-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.